期刊
CLINICAL AND TRANSLATIONAL MEDICINE
卷 11, 期 3, 页码 -出版社
JOHN WILEY & SONS LTD
DOI: 10.1002/ctm2.373
关键词
acute hemolytic transfusion reaction; heme; inhibitor; NLRP3 inflammasome; renal tubular epithelial cells
资金
- National Natural Science Foundations of China [82070196, 82073726]
- Key Research& Development Program of Shaanxi Province [2020SF-226]
This study revealed that heme could activate NLRP3 inflammasome in RTECs, leading to kidney function injury. NLRP3 gene knockout prevented heme-induced damage in RTECs and restored kidney function in AHTR. Furthermore, a novel NLRP3 inflammasome inhibitor, 66PR, bound to NLRP3 protein and inhibited inflammasome activation in RTECs, alleviating heme-induced RTECs injury and kidney function damage in AHTR models.
Background Blood transfusion, a common basic supporting therapy, can lead to acute hemolytic transfusion reaction (AHTR). AHTR poses a great risk to patients through kidney function damage in a short time. Previous reports found that heme from destroyed red blood cells impaired kidney function, and NLR family pyrin domain containing 3 (NLRP3) inflammasome was augmented in case of kidney injury. However, the detailed mechanism regarding whether NLRP3 inflammasome is involved in kidney function injury in AHTR is not fully understood yet. Methods Hemolysis models were established by vein injection with human blood plasma or mouse heme from destroyed red blood cells. The injured renal tubular epithelial cells (RTECs) were evaluated by tubular damage markers staining in hemolysis models and in primary RTECs in vitro. The activation of NLRP3 inflammasome in RTECs by hemes was investigated by Western blot, ELISA, scanning electron microscopy, immunofluorescent staining, flow cytometry, and hemolysis models. NLRP3 gene knockout mice were employed to confirm these observations in vitro and in vivo. The binding between a novel inhibitor (66PR) and NLRP3 was affirmed by molecule docking and co-immunoprecipitation. The rescue of 66PR on kidney function impairment was explored in murine hemolysis models. Results We found that heme could activate NLRP3 inflammasome in RTECs to induce kidney function injury. NLRP3 gene knockout could prevent the damage of RTECs caused by hemes and recover kidney function in AHTR. Moreover, NLRP3 inflammasome chemical inhibitor, 66PR, could bind to NLRP3 protein and inhibit inflammasome activation in RTECs, which consequently relieved the injury of RTECs caused by hemes, and alleviated kidney function damage in the AHTR model. Conclusions Hemes could activate NLRP3 inflammasome in RTECs, and a novel NLRP3 inflammasome inhibitor named 66PR relieved kidney function damage in AHTR. Our findings provided a new possible strategy to treat kidney function failure in AHTR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据